Sirona Biochem Announces Addition of Dr. Brett Premack as Scientific Consultant
Complete the form below to unlock access to ALL audio articles.
Sirona Biochem Corp. has announced the appointment of Dr. Brett Premack as Scientific Consultant.
Dr. Premack will consult and advise on preclinical development activities, particularly pertaining to alliances between public and private research organizations.
"Dr. Brett Premack's expertise in drug discovery and preclinical development will bring tremendous value in the evaluation and development of our therapeutic portfolio," said Dr. Howard Verrico, President & CEO of Sirona Biochem.
"Our chemistry platform technology gives us several program options and our ability to attract high-calibre talent like Dr. Premack enables us to efficiently advance these programs," Dr. Verrico added.
